QualityStocks News - Fisher Scientific's Catalogs to Add International Stem Cell Corp. Lifeline Cell Technology Products
Fisher Scientific, a division of Thermo Fisher Scientific, is the world's largest supplier to the life science industry with over 350,000 customers and $12 billion in annual sales.
Scottsdale, AZ (PRWEB) October 26, 2012
QualityStocks would like to highlight International Stem Cell Corporation (OTCBB: ISCO), focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs).
In the company's news yesterday,
International Stem Cell Corp. announced that its subsidiary, Lifeline Cell Technology (LCT), will start selling its products through Fisher Scientific's online catalog as an Encompass Preferred Supplier.
Large pharmaceutical companies typically buy research supplies and products through preferred supplier agreements. Fisher Scientific, a division of Thermo Fisher Scientific, Inc., is the world's largest such supplier to the life science industry with over 350,000 customers and $12 billion in annual sales. Third party e-catalog sales have grown from $26 million in 2006 to $424 million in 2011. As an encompass preferred supplier, International Stem Cell Corporation's subsidiary gains a promising new sales channel for its cell and media products.
“This is a tremendous opportunity and a testament to the high quality of Life Cell Technology's products,” emphasized Dr. Simon Craw, ISCO's Executive Vice President of Business Development. “By working with Fisher Scientific, LCT will be able to reach many more customers that we would otherwise not be able to reach. One of the biggest challenges we faced was the ability to sell into pharmaceutical companies that have preferred supplier agreements. Our inclusion in the Fisher e-catalogs and Encompass Preferred Suppliers list, not only validates LCT's focus on delivering high quality products but also means these products can now be purchased much more easily by scientists working at the some of the world's largest life science companies.”
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10060025.htmView Comments and Join the Discussion!